What is ASTERA LABS INC's earnings per share (EPS)?

ASTERA LABS INC (ALAB) reported diluted earnings per share of $1.22 for fiscal year 2025. This represents a 290.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ASTERA LABS INC Financials

ALAB

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows ASTERA LABS INC (ALAB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 86/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

ASTERA LABS INC has an operating margin of 20.3%, meaning the company retains $20 of operating profit per $100 of revenue. This strong profitability earns a score of 67/100, reflecting efficient cost management and pricing power. This is up from -29.3% the prior year.

Growth

100

ASTERA LABS INC's revenue surged 115.1% year-over-year to $852.5M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

100

ASTERA LABS INC carries a low D/E ratio of 0.12, meaning only $0.12 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 10.24, ASTERA LABS INC holds $10.24 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

100

ASTERA LABS INC converts 33.1% of revenue into free cash flow ($281.8M). This strong cash generation earns a score of 100/100.

Returns

ASTERA LABS INC's ROE of 16.1% shows moderate profitability relative to equity, earning a score of 47/100. This is up from -8.6% the prior year.

Altman Z-Score Safe

68.45

ASTERA LABS INC scores 68.45, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($18.7B) relative to total liabilities ($168.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

5/9

ASTERA LABS INC passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.46x

For every $1 of reported earnings, ASTERA LABS INC generates $1.46 in operating cash flow ($319.3M OCF vs $219.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$852.5M

YoY+115.1%

ASTERA LABS INC generated $852.5M in revenue in fiscal year 2025. This represents an increase of 115.1% from the prior year.

EBITDA

$180.3M

YoY+259.6%

ASTERA LABS INC's EBITDA was $180.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 259.6% from the prior year.

Net Income

$219.1M

YoY+362.7%

ASTERA LABS INC reported $219.1M in net income in fiscal year 2025. This represents an increase of 362.7% from the prior year.

EPS (Diluted)

$1.22

YoY+290.6%

ASTERA LABS INC earned $1.22 per diluted share (EPS) in fiscal year 2025. This represents an increase of 290.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$281.8M

YoY+175.1%

ASTERA LABS INC generated $281.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 175.1% from the prior year.

Cash & Debt

$167.6M

YoY+110.7%

ASTERA LABS INC held $167.6M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

170M

YoY+5.0%

ASTERA LABS INC had 170M shares outstanding in fiscal year 2025. This represents an increase of 5.0% from the prior year.

Margins & Returns

Gross Margin

75.7%

YoY-0.7pp

ASTERA LABS INC's gross margin was 75.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.7 percentage points from the prior year.

Operating Margin

20.3%

YoY+49.6pp

ASTERA LABS INC's operating margin was 20.3% in fiscal year 2025, reflecting core business profitability. This is up 49.6 percentage points from the prior year.

Net Margin

25.7%

YoY+46.8pp

ASTERA LABS INC's net profit margin was 25.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 46.8 percentage points from the prior year.

Return on Equity

16.1%

YoY+24.7pp

ASTERA LABS INC's ROE was 16.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 24.7 percentage points from the prior year.

Capital Allocation

R&D Spending

$304.0M

YoY+51.4%

ASTERA LABS INC invested $304.0M in research and development in fiscal year 2025. This represents an increase of 51.4% from the prior year.

Share Buybacks

YoY-100.0%

ASTERA LABS INC spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$37.5M

YoY+9.6%

ASTERA LABS INC invested $37.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 9.6% from the prior year.

ALAB Income Statement

Metric	FY25	FY24	FY23	FY22
Revenue	$852.5M+115.1%	$396.3M+242.2%	$115.8M+45.0%	$79.9M
Cost of Revenue	$207.3M+121.5%	$93.6M+160.2%	$36.0M+69.7%	$21.2M
Gross Profit	$645.3M+113.2%	$302.7M+279.2%	$79.8M+36.0%	$58.7M
R&D Expenses	$304.0M+51.4%	$200.8M+173.6%	$73.4M-0.4%	$73.7M
SG&A Expenses	$88.1M-6.6%	$94.3M+492.0%	$15.9M-23.3%	$20.8M
Operating Income	$173.4M+249.4%	-$116.1M-293.5%	-$29.5M+51.0%	-$60.2M
Interest Expense	N/A	N/A	N/A	N/A
Income Tax	-$981K-159.7%	$1.6M-50.3%	$3.3M+333.1%	$764K
Net Income	$219.1M+362.7%	-$83.4M-217.7%	-$26.3M+55.0%	-$58.3M
EPS (Diluted)	$1.22+290.6%	$-0.64+9.9%	$-0.71+58.5%	$-1.71

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$270.6M+17.4%	$230.6M+20.1%	$191.9M+20.4%	$159.4M+13.0%	$141.1M+24.8%	$113.1M+47.2%	$76.8M+17.8%	$65.3M
Cost of Revenue	$66.1M+20.7%	$54.8M+18.1%	$46.4M+15.8%	$40.0M+9.2%	$36.6M+45.4%	$25.2M+48.3%	$17.0M+15.3%	$14.7M
Gross Profit	$204.5M+16.3%	$175.8M+20.8%	$145.6M+21.9%	$119.4M+14.3%	$104.4M+18.9%	$87.9M+46.8%	$59.9M+18.5%	$50.5M
R&D Expenses	$93.8M+18.8%	$78.9M+18.3%	$66.7M+3.4%	$64.6M+14.2%	$56.5M+11.6%	$50.7M+26.4%	$40.1M-25.1%	$53.6M
SG&A Expenses	$23.6M+6.8%	$22.1M+8.1%	$20.5M-6.5%	$21.9M-12.4%	$25.0M+9.2%	$22.9M+3.8%	$22.0M-9.8%	$24.4M
Operating Income	$67.0M+20.8%	$55.4M+39.3%	$39.8M+252.5%	$11.3M+7736.8%	$144K+101.6%	-$8.9M+63.5%	-$24.3M+70.7%	-$83.0M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$33.9M+239.9%	-$24.3M-4230.7%	-$560K+94.5%	-$10.1M+27.9%	-$14.0M-245.8%	$9.6M+247.0%	-$6.5M-152.0%	$12.6M
Net Income	$45.0M-50.6%	$91.1M+77.9%	$51.2M+61.0%	$31.8M+28.8%	$24.7M+425.5%	-$7.6M-0.6%	-$7.5M+91.9%	-$93.0M
EPS (Diluted)	N/A	$0.50+72.4%	$0.29+61.1%	$0.18	N/A	$-0.050.0%	$-0.05+97.2%	$-1.77

ALAB Balance Sheet

Metric	FY25	FY24	FY23	FY22
Total Assets	$1.5B+45.3%	$1.1B+437.2%	$196.3M	N/A
Current Assets	$1.4B+34.5%	$1.0B+445.2%	$185.8M	N/A
Cash & Equivalents	$167.6M+110.7%	$79.6M+76.4%	$45.1M-40.7%	$76.1M
Inventory	$59.0M+36.5%	$43.2M+79.4%	$24.1M	N/A
Accounts Receivable	$83.2M+114.4%	$38.8M+365.6%	$8.3M	N/A
Goodwill	N/A	N/A	N/A	N/A
Total Liabilities	$168.2M+87.5%	$89.7M-69.5%	$294.0M	N/A
Current Liabilities	$133.0M+53.7%	$86.5M+146.7%	$35.1M	N/A
Long-Term Debt	N/A	N/A	N/A	N/A
Total Equity	$1.4B+41.3%	$964.8M+1087.5%	-$97.7M-14.5%	-$85.3M
Retained Earnings	$10.3M+105.0%	-$208.8M-66.5%	-$125.4M	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$1.5B+9.3%	$1.4B+10.2%	$1.3B+13.3%	$1.1B+6.4%	$1.1B+7.3%	$983.1M+7.4%	$915.5M+5.9%	$864.9M
Current Assets	$1.4B+5.6%	$1.3B+9.3%	$1.2B+9.8%	$1.1B+6.2%	$1.0B+7.1%	$945.6M+6.1%	$891.2M+4.3%	$854.4M
Cash & Equivalents	$167.6M+19.4%	$140.4M-13.5%	$162.3M+87.8%	$86.4M+8.6%	$79.6M-36.9%	$126.1M-70.0%	$421.1M-39.5%	$696.1M
Inventory	$59.0M+14.2%	$51.7M-11.8%	$58.6M+14.8%	$51.1M+18.1%	$43.2M+77.0%	$24.4M-14.5%	$28.6M-3.4%	$29.6M
Accounts Receivable	$83.2M+94.0%	$42.9M+76.4%	$24.3M-65.1%	$69.8M+79.8%	$38.8M+52.9%	$25.4M+14.2%	$22.2M+32.7%	$16.8M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$168.2M+29.9%	$129.5M-4.6%	$135.7M+69.3%	$80.1M-10.7%	$89.7M-4.0%	$93.5M+33.0%	$70.3M+25.2%	$56.1M
Current Liabilities	$133.0M+31.8%	$101.0M-5.1%	$106.4M+37.7%	$77.3M-10.7%	$86.5M-1.7%	$88.0M+37.4%	$64.1M+40.6%	$45.6M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.4B+7.2%	$1.3B+12.0%	$1.1B+9.0%	$1.0B+8.0%	$964.8M+8.5%	$889.6M+5.2%	$845.3M+4.5%	$808.8M
Retained Earnings	$10.3M+129.8%	-$34.6M+72.5%	-$125.8M+28.9%	-$177.0M+15.2%	-$208.8M+10.6%	-$233.5M-3.4%	-$225.9M-3.5%	-$218.4M

ALAB Cash Flow Statement

Metric	FY25	FY24	FY23	FY22
Operating Cash Flow	$319.3M+133.6%	$136.7M+1174.8%	-$12.7M+64.6%	-$35.9M
Capital Expenditures	$37.5M+9.6%	$34.2M+1140.3%	$2.8M-28.7%	$3.9M
Free Cash Flow	$281.8M+175.1%	$102.4M+761.8%	-$15.5M+61.1%	-$39.8M
Investing Cash Flow	-$241.5M+68.1%	-$757.6M-4162.7%	-$17.8M+80.4%	-$90.6M
Financing Cash Flow	$9.8M-98.5%	$655.8M+130745.0%	-$502K-100.3%	$151.7M
Dividends Paid	N/A	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$1.1M+407.6%	$210K-32.9%	$313K

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$95.3M+21.9%	$78.2M-42.3%	$135.4M+1188.7%	$10.5M-73.5%	$39.7M-37.5%	$63.5M+113.0%	$29.8M+716.3%	$3.7M
Capital Expenditures	$18.7M+52.0%	$12.3M+507.7%	$2.0M-55.4%	$4.5M-70.6%	$15.4M-7.5%	$16.7M+1361.1%	-$1.3M-138.7%	$3.4M
Free Cash Flow	$76.6M+16.2%	$65.9M-50.6%	$133.3M+2135.4%	$6.0M-75.4%	$24.3M-48.2%	$46.8M+64.3%	$28.5M+12395.2%	$228K
Investing Cash Flow	-$72.8M+28.0%	-$101.0M-58.6%	-$63.7M-1516.6%	-$3.9M+95.7%	-$91.4M+74.6%	-$359.4M-18.8%	-$302.5M-7015.3%	-$4.3M
Financing Cash Flow	$3.7M+291.6%	$952K-79.9%	$4.7M+1127.2%	$386K-93.2%	$5.7M+493.6%	$952K+140.6%	-$2.3M-100.4%	$651.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ALAB Financial Ratios

Metric	FY25	FY24	FY23	FY22
Gross Margin	75.7%-0.7pp	76.4%+7.4pp	68.9%-4.5pp	73.5%
Operating Margin	20.3%+49.6pp	-29.3%-3.8pp	-25.5%+49.9pp	-75.4%
Net Margin	25.7%+46.8pp	-21.1%+1.6pp	-22.7%+50.4pp	-73.0%
Return on Equity	16.1%+24.7pp	-8.6%	N/A	N/A
Return on Assets	14.3%+22.2pp	-7.9%+5.5pp	-13.4%	N/A
Current Ratio	10.24-1.5	11.71+6.4	5.30	N/A
Debt-to-Equity	0.12+0.0	0.09+3.1	-3.01	N/A
FCF Margin	33.1%+7.2pp	25.9%+39.2pp	-13.4%+36.4pp	-49.8%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	75.6%-0.7pp	76.3%+0.4pp	75.8%+0.9pp	74.9%+0.9pp	74.0%-3.7pp	77.7%-0.2pp	77.9%+0.5pp	77.4%
Operating Margin	24.8%+0.7pp	24.0%+3.3pp	20.7%+13.6pp	7.1%+7.0pp	0.1%+8.0pp	-7.9%+23.8pp	-31.7%+95.5pp	-127.1%
Net Margin	16.6%-22.9pp	39.5%+12.8pp	26.7%+6.7pp	20.0%+2.4pp	17.5%+24.2pp	-6.7%+3.1pp	-9.8%+132.7pp	-142.5%
Return on Equity	3.3%-3.9pp	7.2%+2.6pp	4.5%+1.5pp	3.0%+0.5pp	2.6%+3.4pp	-0.9%+0.0pp	-0.9%+10.6pp	-11.5%
Return on Assets	2.9%-3.6pp	6.5%+2.5pp	4.0%+1.2pp	2.8%+0.5pp	2.3%+3.1pp	-0.8%+0.1pp	-0.8%+9.9pp	-10.8%
Current Ratio	10.24-2.5	12.78+1.7	11.10-2.8	13.92+2.2	11.71+1.0	10.74-3.2	13.91-4.8	18.74
Debt-to-Equity	0.12+0.0	0.10-0.0	0.12+0.0	0.08-0.0	0.09-0.0	0.10+0.0	0.08+0.0	0.07
FCF Margin	28.3%-0.3pp	28.6%-40.9pp	69.5%+65.7pp	3.7%-13.5pp	17.2%-24.2pp	41.4%+4.3pp	37.1%+36.7pp	0.4%

Similar Companies

Monolithic Power MPWR

$53.7B

Microchip Technology Inc. MCHP

$35.0B

CREDO TECHNOLOGY GROUP HOLDING CRDO

$17.3B

Nxp Semiconduct NXPI

$49.7B

Marvell Technology Inc MRVL

$86.6B

Frequently Asked Questions

What is ASTERA LABS INC's annual revenue?

ASTERA LABS INC (ALAB) reported $852.5M in total revenue for fiscal year 2025. This represents a 115.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ASTERA LABS INC's revenue growing?

ASTERA LABS INC (ALAB) revenue grew by 115.1% year-over-year, from $396.3M to $852.5M in fiscal year 2025.

Is ASTERA LABS INC profitable?

Yes, ASTERA LABS INC (ALAB) reported a net income of $219.1M in fiscal year 2025, with a net profit margin of 25.7%.

What is ASTERA LABS INC's EBITDA?

ASTERA LABS INC (ALAB) had EBITDA of $180.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is ASTERA LABS INC's gross margin?

ASTERA LABS INC (ALAB) had a gross margin of 75.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is ASTERA LABS INC's operating margin?

ASTERA LABS INC (ALAB) had an operating margin of 20.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is ASTERA LABS INC's net profit margin?

ASTERA LABS INC (ALAB) had a net profit margin of 25.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is ASTERA LABS INC's return on equity (ROE)?

ASTERA LABS INC (ALAB) has a return on equity of 16.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is ASTERA LABS INC's free cash flow?

ASTERA LABS INC (ALAB) generated $281.8M in free cash flow during fiscal year 2025. This represents a 175.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is ASTERA LABS INC's operating cash flow?

ASTERA LABS INC (ALAB) generated $319.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are ASTERA LABS INC's total assets?

ASTERA LABS INC (ALAB) had $1.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are ASTERA LABS INC's capital expenditures?

ASTERA LABS INC (ALAB) invested $37.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does ASTERA LABS INC spend on research and development?

ASTERA LABS INC (ALAB) invested $304.0M in research and development during fiscal year 2025.

How many shares does ASTERA LABS INC have outstanding?

ASTERA LABS INC (ALAB) had 170M shares outstanding as of fiscal year 2025.

What is ASTERA LABS INC's current ratio?

ASTERA LABS INC (ALAB) had a current ratio of 10.24 as of fiscal year 2025, which is generally considered healthy.

What is ASTERA LABS INC's debt-to-equity ratio?

ASTERA LABS INC (ALAB) had a debt-to-equity ratio of 0.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ASTERA LABS INC's return on assets (ROA)?

ASTERA LABS INC (ALAB) had a return on assets of 14.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is ASTERA LABS INC's Altman Z-Score?

ASTERA LABS INC (ALAB) has an Altman Z-Score of 68.45, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is ASTERA LABS INC's Piotroski F-Score?

ASTERA LABS INC (ALAB) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ASTERA LABS INC's earnings high quality?

ASTERA LABS INC (ALAB) has an earnings quality ratio of 1.46x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is ASTERA LABS INC?

ASTERA LABS INC (ALAB) scores 86 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.